DSIJ Mindshare

The shares of Bharti Airtel Limited took a hit of around 2 per cent as the company was issued a demand notice, charging penalties worth Rs. 11 lakh for the quarter ending March 2018. 

Sun Pharma’s Mohali plant in Punjab is undergoing a three-day surprise investigation by the USFDA. The investigation commenced on September 10, 2018, confirmed the company in an exchange filing. The company is of the opinion that the investigation will not cause any material impact.

Cipla’s first-line triple-combination treatment for HIV receives approval from the South African Health Products Regulatory Authority (SAHPRA). The newly developed combination drug will be produced locally for the African market.

Narayana Hrudayalaya’s step-down subsidiary, NH Health Bangladesh, has entered into definitive agreements to partner with Imperial Hospital in Chittagong, Bangladesh to operate and manage their cardiac sciences department.

Overall volumes in futures & options currently stand at 1.24 crore contracts with a turnover of Rs. 12,62,935.13 crore.